Imatinib vs Irbesartan
Imatinib vs Irbesartan: Overview
This comparison examines the pharmacological differences between Imatinib and Irbesartan.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.
Pharmacokinetics
Half-life: Imatinib β 18 hours; Irbesartan β 11-15 hours.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O; Irbesartan β C25H28N6O.
Molecular Weight: Imatinib β 493.6030 g/mol; Irbesartan β 428.5320 g/mol.
Type: Imatinib β Small molecule; Irbesartan β Small molecule.